849353-56-6

Basic information

• Product Name: 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid
• Synonyms: 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid;3-(5-fluoro-2-methylphenyl)-3-methylbutyric acid;Benzenepropanoic acid, 5-fluoro-β,β,2-trimethyl-
• CAS NO: 849353-56-6
• Molecular Formula: C₁₂H₁₅FO₂
• Molecular Weight: 210.2447032
• Mol File: 849353-56-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid(849353-56-6)
• EPA Substance Registry System: 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid(849353-56-6)

Safety Data

• Hazardous Substances Data: 849353-56-6(Hazardous Substances Data)

Usage

General Description

3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid is a chemical compound with a molecular formula C12H15FO2. It is a derivative of butyric acid and belongs to the class of organic compounds known as fatty acids and conjugates. 3-(5-fluoro-2-Methylphenyl)-3-Methylbutanoic acid is a colorless to pale yellow liquid with a slightly sweet odor. It is used as a flavoring agent in the food industry and as a precursor in the synthesis of pharmaceuticals. Additionally, it has been studied for its potential therapeutic applications, including its anti-inflammatory and analgesic properties.

Upstream product

• 1192941-07-3 2-[1-(5-fluoro-2-methylphenyl)-1-methylethyl]malonic acid diethyl ester 

Downstream Products

• 875415-40-0 2-Cyclopropyl-4-(5-fluoro-2-methylphenyl)-4-methyl-1-(1H-pyrrolo[3,2-c]pyridin-2-yl)pentan-2-ol 
• 1348152-65-7 C₂₄H₃₁FN₂O 

Relevant articles and documents

Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore

Synthesis and structure-activity relationship (SAR) of a series of alkyl and cycloalkyl containing non-steroidal dissociated glucocorticoid receptor (GR) agonists is reported. This series of compounds was identified as part of an effort to replace the CF

1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO

Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.